Drug company fails to stop publication of reportBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7151.101 (Published 11 July 1998) Cite this as: BMJ 1998;317:101
- David Spurgeon
A legal dispute over the publication of a report on cholesterol lowering drugs has been won by the Canadian Coordinating Office for Health Technology Assessment (CCOHTA).
Bristol-Myers Squibb Canada tried to prevent publication of a report on statins produced by the independent technology assessment body, claiming that it would negatively affect the sales of their drug pravastatin (Pravachol). The company lost both its original case last December and an appeal in May.
CCOHTA, a non-profit corporation founded and funded by …